GL1X · GenesisL1 explorer

MolNFT v1 · #2189 · protein

Structure-based design and synthesis of lipophilic 2,4-diamino-6- substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductase and potential antitumor agents

1BOZ: “Structure-based design and synthesis of lipophilic 2,4-diamino-6- substituted quinazolines and their…”. X-ray diffraction. MolNFT v1 #2189 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1BOZ
Type
protein
Length
186 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P00374

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein186—P00374

Compared structures

  • 1BOZ · Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00374 · AlphaFold monomer V2.0 prediction for dihydrofolate reductase (P00374) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.